Elan's Irish Tax Base Becomes Perrigo's Pot of Gold

July 29 (Bloomberg) -- Bloomberg's Olivia Sterns reports on the $8.6 billion by Perrigo Co. to purchase Irish drug company Elan Corp. and the tax relief Ireland's tax-base may bring to the drugmaker, plus a look at what may be a split of internal operations by Pfizer. She speaks on Bloomberg Television's "Market Makers."

Most Recent Videos

How Apple Conquered China Market: Bloomberg West (01/30)
21:52 - Jan. 30 -- Full episode of "Bloomberg West." Guests: GGV Capital's Hans Tung, Strategic Analytics' Neil Mawston, Evercore ISI's Ken Sena, CKE Restaurants CEO Andrew Puzder, Boost VC CEO Adam Draper and Zebra Technologies' Jill Stelfox.
  • Should Amazon Spin Off Its Growing Cloud Business?
  • TripAdvisor's Top Pick: Chicago's Langham Hotel
  • Dan Marino: Roger Goodell Has Done a Really Good Job